Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6366107 | 0.76 | APEX1 (0.36) | ALDH1A1GAAAPEX1MAPTNLRP3 | |
| SCHEMBL9921596 | 0.72 | GAA (0.38) | ALDH1A1GAAAPEX1CRHBPCRHR2 | |
| SCHEMBL9345878 | 0.71 | LMNA (0.39) | GAA | |
| SCHEMBL17484747 | 0.70 | ALDH1A1 (0.32) | ALDH1A1GAAPKM | |
| SCHEMBL6365346 | 0.70 | ALDH1A1 (0.52) | ALDH1A1GAAAPEX1MAPTNLRP3 | |
| SCHEMBL3737916 | 0.69 | TP53 (0.38) | NLRP3 | |
| SCHEMBL11224624 | 0.68 | APEX1 (0.40) | GAAAPEX1CRHBPCRHR2 | |
| SCHEMBL7248680 | 0.67 | GAA (0.33) | GAACRHBPCRHR2NLRP3 | |
| SCHEMBL436830 | 0.67 | GAA (0.33) | GAACRHBPCRHR2NLRP3 | |
| SCHEMBL1994684 | 0.67 | CRHBP (0.63) | ALDH1A1GAACRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160031767-A1 | PHOTOACTIVE ENERGETIC MATERIALS | TRIAD NATIONAL SECURITY, LLC | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160031767-A1 | PHOTOACTIVE ENERGETIC MATERIALS | NOX5, TRPM5, MT-ND5 | ALDH1A1 706/4885GAA 1583/4885APEX1 272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.